Simplified medication regimen and survival in polypathological patients

Ollero-Baturone, 2007 García-Morillo, 2005, Incidencia y características clínicas de los pacientes con pluripatología ingresados en una unidad de medicina interna, Med Clin (Barc), 125, 5, 10.1157/13076399 Díez-Manglano, 2013, on behalf of the PLUPAR study researchers. Differential characteristics in polypathological inpatients in internal medicine departments and acute geriatric units: the PLUPAR study, Eur J Intern Med, 24, 767, 10.1016/j.ejim.2013.07.010 Boyd, 2005, Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. Implications for pay for performance, JAMA, 294, 716, 10.1001/jama.294.6.716 Vyas, 2012, Chronic condition clusters and polypharmacy among adults, Int J Fam Med, 10.1155/2012/193168 Bernabeu-Wittel, 2011, A multi-institutional, hospital-based assessment of clinical, functional, sociofamilial and health-care characteristics of polypathological patients (PP), Arch Gerontol Geriatr, 53, 284, 10.1016/j.archger.2010.12.006 Gómez Aguirre, 2017, Poplypathology, polypharmacy medication régimen complexity and drug therapy appropiateness, Rev Clin Esp, 217, 289, 10.1016/j.rce.2016.12.013 Díez-Manglano, 2015, on behalf of the PLUPAR Study Researchers. Excessive polypharmacy and survival in polypathological patients, Eur J Clin Pharmacol, 71, 733, 10.1007/s00228-015-1837-8 Bellostas Muñoz, 2018, Complejidad del régimen de medicación en pacientes pluripatológicos, Rev Clin Esp, 218, 342, 10.1016/j.rce.2018.04.009 Pantuzza, 2017, Association between medication regimen complexity and pharmacotherapy adherence: a systematic review, Eur J Clin Pharmacol, 73, 1475, 10.1007/s00228-017-2315-2 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Lawton, 1969, Assessment of older people: self maintaining and instrumental activities of daily living, Gerontologist, 9, 179, 10.1093/geront/9.3_Part_1.179 Mahoney, 1965, Functional evaluation: the Barthel Index, Md State Med J, 4, 61 Martínez de la Iglesia, 2001, Spanish language adaptation and validation of the Pfeiffer´s questionnaire (SPMSQ) to detect cognitive deterioration in people over 65 years of age, Med Clin (Barc), 117, 129 Alarcón, 1988, La escala sociofamiliar de Gijón, elemento útil en el hospital general, Rev Esp Geriatr Gerontol, 33, 178 Bernabeu-Wittel, 2011, Development of a new predictive model for polypathological patients. The PROFUND index, Eur J Intern Med, 22, 311, 10.1016/j.ejim.2010.11.012 George, 2004, Development and validation of the Medication Regimen Complexity Index, Ann Pharmacother, 38, 1369, 10.1345/aph.1D479 Wimmer, 2017, Clinical outcomes associated with medication regimen complexity in older people: a systematic review, J Am Geriatr Soc, 65, 747, 10.1111/jgs.14682 Alves-Coceição, 2018, Medication regimen complexity measured by MRCI: a systematic review to identify health outcomes, Ann Pharmacother, 52, 1117, 10.1177/1060028018773691 Lalic, 2016, Polypharmacy and medication regimen complexity as factors associated with staff informant rated quality of life in residentsof aged care facilities: a cross-sectional study, Eur J Clin Pharmacol, 72, 1117, 10.1007/s00228-016-2075-4 Fröhlich, 2010, Association between drug prescribing and quality of life in primary care, Pharm World Sci, 32, 744, 10.1007/s11096-010-9431-8 Schoonover, 2014, Predicting potential postdischarge adverse drug events and 30-day unplanned hospital readmissions from medication regimen complexity, J Patient Saf, 10, 186, 10.1097/PTS.0000000000000067 Willson, 2014, Medication regimen complexity and hospital readmission for an adverse drug event, Ann Pharmacother, 48, 26, 10.1177/1060028013510898 Colavecchia, 2017, Discharge medication complexity and 30-day heart failure readmissions, Res Social Adm Pharm, 13, 857, 10.1016/j.sapharm.2016.10.002 Abou-Karam, 2016, Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease, SAGE Open Med, 4, 1, 10.1177/2050312116632426 Wimmer, 2014, Medication regimen complexity and unplanned hospital readmissions in older people, Ann Pharmacother, 48, 1120, 10.1177/1060028014537469 Leelakanok, 2017, Association between polypharmacy and death: a systematic review and meta-analysis, J Am Pharm Assoc, 57, 729, 10.1016/j.japh.2017.06.002 Wimmer, 2016, Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study, Ann Pharmacother, 50, 89, 10.1177/1060028015621071 Johansson, 2016, Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis, Br J Clin Pharmacol, 82, 532, 10.1111/bcp.12959 Ryan, 2014, Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews, Cochrane Database Syst Rev, 29 Lepelley, 2018, Electronic Medication Regimen Complexity Index at admission and complications during hospitalization in medical wards: a tool to improve quality of care?, Int J Qual Health Care, 30, 32, 10.1093/intqhc/mzx168 Elliott, 2013, Impact of an intervention to reduce medication regimen complexity for older hospital inpatients, Int J Clin Pharm, 35, 217, 10.1007/s11096-012-9730-3 Stange, 2013, Reducing cardiovascular medication complexity in a German university hospital: effects of a structured pharmaceutical management intervention on adherence, J Manag Care Pharm, 19, 396, 10.18553/jmcp.2013.19.5.396